Syneos Health and KX have entered into a strategic partnership to pioneer data-driven transformation in biopharmaceutical asset development.

The collaboration aims to deliver artificial intelligence (AI) and machine learning (ML) data-driven predictive analytics to help address complex healthcare decisions through new class of data and AI management engine, Data Timehouse.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Data Timehouse has been designed for temporal data generated by digital transformation.

This will offer real-time engagement and quick and more accurate decision-making related to selection of drug trial site. Syneos Health and KX will work to reduce costs, improve clinical trial efficiency, and speed to market time for therapies, through the partnership.

Syneos Health Technology and Data Solutions president Baba Shetty said: “Our KX partnership advances our ability to deliver data driven insights and AI enabled solutions, helping biopharma customers solve their most complex clinical development and commercialisation challenges.

“We’ve seen first-hand with multiple customers the ability of KX to dramatically accelerate the most challenging computational challenges with massive data sets, supporting use cases including patient simulations (QSP) for clinical and omnichannel/Real World Evidence for commercial.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The company stated that the collaboration with KX will help empower biopharmaceutical customers to solve complex healthcare decisions through data. Earlier it entered into a strategic collaboration with Microsoft for expediting AI across the clinical to commercial continuum.

Syneos Health and KX will use the Azure technology from Microsoft to bring the potential benefits of AI, ML and tech-enabled solutions to customers.

Azure technology will be used to provide customers with data-driven insights that will help in improving the effectiveness, efficiency, and performance across the asset development lifecycle.

Clinical Trials Arena Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Clinical Trials Arena Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving clinical trials industry advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now